Qiagen NV (QGEN) Releases Earnings Results, Beats Expectations By $0.02 EPS

Qiagen NV (QGEN) reported quarterly earnings results on Thursday, Jul-28-2016. The company said it had a profit of $0.24 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.02. Analysts had a consensus of $0.22. The company posted revenue of $334.40 million in the period, compared to analysts expectations of $326.41 million. The company’s revenue was up 4.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.26 EPS.

Qiagen NV opened for trading at $23.24 and hit $23.585 on the upside on Thursday, eventually ending the session at $23.43, with a gain of 1.47% or 0.34 points. The heightened volatility saw the trading volume jump to 14,13,884 shares. Company has a market cap of $5,468 M.

QIAGEN N.V. (QIAGEN) is a Netherlands-based holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies bioinformatics and automation systems. Sample to Insight molecular technologies are applicable across a range of applications and customer classes through more than 500 core consumable products as well as instruments that automate the use of these products for sample preparation analysis and interpretation. The Company’s bioinformatics solutions connect laboratory workflows and process amounts of genomic data enabling scientists or clinicians to interpret results and decide on further action.

Qiagen NV

Leave a Reply

Qiagen NV - Is it time to Sell?

Top Brokerage Firms are advising their investors on Qiagen NV. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.